This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
FDA Inspections of Abbott 2019, 2021 and 2022. The FDA, along with CDC and state and local partners are investigating consumer complaints and/or reports of infant illness related to products from Abbott Nutrition’s Sturgis, MI facility. Additional recall information for the initial recall is available on the FDA website.
A Trip Down Memory Lane Weight loss medications have been part of medical history since the FDA approved the first one in 1947. The advent of GLP-1 receptor agonists in 2014, and their increased use in recent years, revolutionized obesity treatment. However, next-gen obesity medications have been game-changers.
Food and Drug Administration (FDA) is the lead U.S. Initiatives like FDAs Closer To Zero program are actively working to reduce exposure to cadmium and other heavy metals for all ages. The FDA has a temporary intake guideline of 0.210.36 The FDA identifies effects on kidney and bone as the most sensitive areas impacted.
Food and Drug Administration (FDA) is the lead U.S. Initiatives like FDAs Closer To Zero program are actively working to reduce exposure to arsenic and other heavy metals for all ages. Food and Drug Administration (FDA) is the lead U.S. Agency for protecting the public from overexposure to arsenic in food.
“This increased the visibility of food safety in the United States, and provided one of the first examples in which the safety of food was directly linked to public health,” says Lee-Ann Jaykus, PhD, distinguished professor of food, bioprocessing, and nutrition sciences at North Carolina State University in Raleigh. “It
Dr. Betters agreed with nephrology’s recommendation to start Makayla on nutritional support with TPN [12] plus intralipids (IL), with a plan to wean her off intravenous fluids once those were well established. Makayla had been exhibiting elevated potassium levels on TPN, so nutritional adjustments were made.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content